Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?

類似資料

• <i>Lactobacillus</i> Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of <i>Pseudomonas aeruginosa</i> from Cystic Fibrosis Lung
  著者:: Giovanna Batoni, 等
  出版事項: (2023-06-01)
• Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
  著者:: Gabriella d'Ettorre, 等
  出版事項: (2020-07-01)
• Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of <i>Pseudomonas aeruginosa</i> under Conditions Relevant to Cystic Fibrosis
  著者:: Giovanna Batoni, 等
  出版事項: (2023-07-01)
• Convergence of Nanotechnology and Bacteriotherapy for Biomedical Applications
  著者:: Jun Liu, 等
  出版事項: (2024-04-01)
• Bacteriotherapy for inflammatory bowel disease
  著者:: Yusuke Yoshimatsu, 等
  出版事項: (2021-01-01)